A Mathematical Methodology for Determining the Temporal Order of Pathway Alterations Arising during Gliomagenesis
暂无分享,去创建一个
Franziska Michor | Rameen Beroukhim | Eric C. Holland | Ingo K. Mellinghoff | Yu-Kang Cheng | Ross L. Levine | R. Beroukhim | I. Mellinghoff | R. Levine | E. Holland | F. Michor | Yu-Kang Cheng
[1] E. Domany,et al. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Jens Lagergren,et al. New Probabilistic Network Models and Algorithms for Oncogenesis , 2006, J. Comput. Biol..
[3] Maode Lai,et al. -8p12-23 and +20q are predictors of subtypes and metastatic pathways in colorectal cancer: construction of tree models using comparative genomic hybridization data. , 2011, Omics : a journal of integrative biology.
[4] C. Sander,et al. Automated Network Analysis Identifies Core Pathways in Glioblastoma , 2010, PloS one.
[5] M. Berger,et al. Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. , 2001, Cancer research.
[6] W Arap,et al. Loss of P16INK4 expression is frequent in high grade gliomas. , 1995, Cancer research.
[7] K. Lim,et al. Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance. , 2005, Cancer cell.
[8] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[9] B. Iacopetta,et al. p53 and disease: when the guardian angel fails , 2006, Cell Death and Differentiation.
[10] F Vogel,et al. Spontaneous mutation in man. , 1975, Advances in human genetics.
[11] Alejandro A Schäffer,et al. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression , 2002, Genes, chromosomes & cancer.
[12] G. Parmigiani,et al. The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.
[13] Ji Luo,et al. Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction , 2009, Cell.
[14] Gary D. Bader,et al. Pathway Commons, a web resource for biological pathway data , 2010, Nucleic Acids Res..
[15] A. Jackson,et al. The mutation rate and cancer. , 1998, Genetics.
[16] Carlotta Costa,et al. Taming the PI3K team to hold inflammation and cancer at bay. , 2008, Pharmacology & therapeutics.
[17] A. Schäffer,et al. Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis , 2000, Genes, chromosomes & cancer.
[18] E. Lander,et al. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.
[19] Y. Yonekawa,et al. Overexpression of the EGF Receptor and p53 Mutations are Mutually Exclusive in the Evolution of Primary and Secondary Glioblastomas , 1996 .
[20] D. Louis,et al. Molecular Genetic Correlates of p16, cdk4, and pRb Immunohistochemistry in Glioblastomas , 1998, Journal of neuropathology and experimental neurology.
[21] C. Brennan,et al. Molecular subclassification of diffuse gliomas: Seeing order in the chaos , 2011, Glia.
[22] Thomas Lengauer,et al. Learning multiple evolutionary pathways from cross-sectional data , 2004, J. Comput. Biol..
[23] J. Mesirov,et al. GenePattern 2.0 , 2006, Nature Genetics.
[24] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[25] Axel Benner,et al. Oncogenetic tree modeling of human hepatocarcinogenesis , 2012, International journal of cancer.
[26] Yasuhiro Yonekawa,et al. Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas , 1997, Acta Neuropathologica.
[27] Niko Beerenwinkel,et al. Quantifying cancer progression with conjunctive Bayesian networks , 2009, Bioinform..
[28] Niko Beerenwinkel,et al. Construction of oncogenetic tree models reveals multiple pathways of oral cancer progression , 2009, International journal of cancer.
[29] Kei-Hoi Cheung,et al. BioPAX – A community standard for pathway data sharing , 2010, Nature Biotechnology.
[30] P. Rousseeuw. Silhouettes: a graphical aid to the interpretation and validation of cluster analysis , 1987 .
[31] R. Mirimanoff,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[32] Camille Stephan-Otto Attolini,et al. A mathematical framework to determine the temporal sequence of somatic genetic events in cancer , 2010, Proceedings of the National Academy of Sciences.
[33] D. Louis,et al. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. , 1996, Cancer research.
[34] W Arap,et al. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. , 1997, Cancer research.
[35] J. Lupski,et al. Genomic rearrangements and sporadic disease , 2007, Nature Genetics.
[36] Roland Penzel,et al. Oncogenetic tree models based on cytogenetic data: new insights into the development of epithelial tumors of the thymus. , 2005, Cancer genetics and cytogenetics.
[37] Y Sawamura,et al. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression. , 1999, Neuro-oncology.
[38] I. Weinstein. Addiction to Oncogenes--the Achilles Heal of Cancer , 2002, Science.
[39] A. Liebman,et al. Systematic Reviews: Synthesis of Best Evidence for Health Care Decisions , 1998, Annals of Internal Medicine.
[40] A. W. F. Edwards,et al. The statistical processes of evolutionary theory , 1963 .
[41] Santosh Kesari,et al. Molecular pathogenesis of adult brain tumors and the role of stem cells. , 2007, Neurologic clinics.
[42] Wael M Abdel-Rahman,et al. Genomic Instability and Carcinogenesis: An Update , 2008, Current genomics.
[43] Jayant P. Menon,et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. , 2006, Cancer cell.
[44] Alberto Mantovani,et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.
[45] Y. Yonekawa,et al. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. , 1996, Brain pathology.
[46] Sanjay Ranka,et al. Gene expression Distance-based clustering of CGH data , 2006 .
[47] A. Jeffreys,et al. Processes of copy-number change in human DNA: the dynamics of {alpha}-globin gene deletion. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[48] Feng Jiang,et al. Distance-Based Reconstruction of Tree Models for Oncogenesis , 2000, J. Comput. Biol..
[49] T. Kunkel. DNA Replication Fidelity* , 2004, Journal of Biological Chemistry.
[50] T. Halazonetis,et al. Genomic instability — an evolving hallmark of cancer , 2010, Nature Reviews Molecular Cell Biology.
[51] Feng Jiang,et al. Inferring Tree Models for Oncogenesis from Comparative Genome Hybridization Data , 1999, J. Comput. Biol..
[52] Nader Sanai,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma. , 2010, World neurosurgery.
[53] J. Crow,et al. Spontaneous mutation in man. , 1999, Mutation research.
[54] Gunter Haroske,et al. Comparative genomic hybridization-based oncogenetic tree model for genetic classification of breast cancer. , 2009, Analytical and quantitative cytology and histology.
[55] Martin A. Nowak,et al. Genetic Progression and the Waiting Time to Cancer , 2007, PLoS Comput. Biol..
[56] K. Aldape,et al. Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. , 2001, Cancer research.
[57] M Aickin,et al. Chromosome abnormalities in ovarian adenocarcinoma: I. nonrandom chromosome abnormalities from 244 cases , 1999, Genes, chromosomes & cancer.
[58] Thomas D. Wu,et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.
[59] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[60] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[61] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[62] C. Brennan,et al. Glioblastoma Subclasses Can Be Defined by Activity among Signal Transduction Pathways and Associated Genomic Alterations , 2009, PloS one.
[63] K. Kinzler,et al. Genetic instabilities in human cancers , 1998, Nature.
[64] Robert A Beckman,et al. Genetic instability is not a requirement for tumor development. , 2008, Cancer research.
[65] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[66] Mattias Höglund,et al. Statistical behavior of complex cancer karyotypes , 2005, Genes, chromosomes & cancer.
[67] Eric C. Holland,et al. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice , 2000, Nature Genetics.
[68] M. Stratton,et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website , 2004, British Journal of Cancer.
[69] L. Chin,et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.
[70] F. Haller,et al. An oncogenetic tree model in gastrointestinal stromal tumours (GISTs) identifies different pathways of cytogenetic evolution with prognostic implications , 2007, The Journal of pathology.
[71] C. Sander,et al. Functional Copy-Number Alterations in Cancer , 2008, PloS one.
[72] Jill P. Mesirov,et al. Consensus Clustering: A Resampling-Based Method for Class Discovery and Visualization of Gene Expression Microarray Data , 2003, Machine Learning.